Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents

Background. The commercially-available C6 Lyme enzyme immunoassay (EIA) has been approved to replace the standard whole-cell sonicate EIA as a first-tier test for the diagnosis of Lyme disease and has been suggested as a stand-alone diagnostic. However, the C6 EIA has not been extensively studied in...

Full description

Saved in:
Bibliographic Details
Published in:Clin Infect Dis
Main Authors: Lipsett, Susan C., Branda, John A., McAdam, Alexander J., Vernacchio, Louis, Gordon, Caroline D., Gordon, Catherine R., Nigrovic, Lise E.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2016
Subjects:
Articles and Commentaries
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019286/
https://ncbi.nlm.nih.gov/pubmed/27358358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw427
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items